Mortgage-Backed and Credit Risk Transfer Securities |
Mortgage-Backed and Credit Risk Transfer Securities The following tables summarize our mortgage-backed securities ("MBS") and GSE CRT portfolio by asset type as of June 30, 2017 and December 31, 2016. | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2017 | | | | | | | | | | | | | | | | $ in thousands | Principal/ Notional Balance | | Unamortized Premium (Discount) | | Amortized Cost | | Unrealized Gain/ (Loss), net | | Fair Value | | Net Weighted Average Coupon (1) | | Period- end Weighted Average Yield (2) | | Quarterly Weighted Average Yield (3) | Agency RMBS: | | | | | | | | | | | | | | | | 15 year fixed-rate | 3,187,931 |
| | 134,856 |
| | 3,322,787 |
| | (46,007 | ) | | 3,276,780 |
| | 3.09 | % | | 2.19 | % | | 1.97 | % | 30 year fixed-rate | 4,816,054 |
| | 232,385 |
| | 5,048,439 |
| | 20,677 |
| | 5,069,116 |
| | 3.95 | % | | 3.10 | % | | 2.83 | % | ARM* | 269,123 |
| | 1,988 |
| | 271,111 |
| | 3,463 |
| | 274,574 |
| | 2.68 | % | | 2.58 | % | | 2.27 | % | Hybrid ARM | 1,891,257 |
| | 30,099 |
| | 1,921,356 |
| | 12,659 |
| | 1,934,015 |
| | 2.71 | % | | 2.54 | % | | 2.29 | % | Total Agency pass-through(4) | 10,164,365 |
| | 399,328 |
| | 10,563,693 |
| | (9,208 | ) | | 10,554,485 |
| | 3.42 | % | | 2.69 | % | | 2.44 | % | Agency-CMO(5) | 1,429,977 |
| | (1,129,678 | ) | | 300,299 |
| | (2,033 | ) | | 298,266 |
| | 2.04 | % | | 2.87 | % | | 0.34 | % | Non-Agency RMBS(6)(7)(8) | 3,247,516 |
| | (1,793,760 | ) | | 1,453,756 |
| | 122,084 |
| | 1,575,840 |
| | 2.18 | % | | 5.80 | % | | 5.90 | % | GSE CRT(9)(10) | 769,217 |
| | 25,537 |
| | 794,754 |
| | 82,423 |
| | 877,177 |
| | 3.06 | % | | 2.40 | % | | 2.62 | % | CMBS(11)(12) | 3,317,888 |
| | (612,386 | ) | | 2,705,502 |
| | 72,014 |
| | 2,777,516 |
| | 3.90 | % | | 4.62 | % | | 4.45 | % | Total | 18,928,963 |
| | (3,110,959 | ) | | 15,818,004 |
| | 265,280 |
| | 16,083,284 |
| | 3.17 | % | | 3.30 | % | | 3.07 | % |
* Adjustable-rate mortgage ("ARM") | | (1) | Net weighted average coupon as of June 30, 2017 is presented net of servicing and other fees. |
| | (2) | Period-end weighted average yield is based on amortized cost as of June 30, 2017 and incorporates future prepayment and loss assumptions. |
| | (3) | Quarterly weighted average portfolio yield for the period was calculated by dividing interest income, including amortization of premiums and discounts, by the average balance of the amortized cost of the investments. All yields are annualized. |
| | (4) | We have elected the fair value option for Agency RMBS purchased on or after September 1, 2016 which represent 23.7% of principal/notional balance, 23.5% of amortized cost and 23.5% of fair value. |
| | (5) | Agency collateralized mortgage obligation ("Agency-CMO") includes interest-only securities ("Agency IO"), which represent 84.3% of principal/notional balance, 24.1% of amortized cost and 23.9% of fair value. |
| | (6) | Non-Agency RMBS held by us is 43.8% fixed rate, 48.0% variable rate, and 8.2% floating rate based on fair value. |
| | (7) | Of the total discount in non-Agency RMBS, $258.2 million is non-accretable based on estimated future cash flows of the securities. |
| | (8) | Non-Agency RMBS includes interest-only securities which represent 47.7% of principal/notional balance, 1.8% of amortized cost and 1.5% of fair value. |
| | (9) | We have elected the fair value option for GSE CRT purchased on or after August 24, 2015, which represent 26.1% of the balance based on fair value. As a result, GSE CRT accounted for under the fair value option are not bifurcated between the debt host contract and the embedded derivative. |
| | (10) | GSE CRT weighted average coupon and weighted average yield excludes coupon interest associated with embedded derivatives not accounted for under the fair value option that is recorded as realized and unrealized credit derivative income (loss), net. |
| | (11) | CMBS includes interest-only securities which represent 18.5% of principal/notional balance, 0.7% of amortized cost and 0.7% of fair value. |
| | (12) | We have elected the fair value option for CMBS purchased on or after September 1, 2016 which represent 10.6% of principal/notional balance, 11.3% of amortized cost and 11.0% of fair value. |
| | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2016 | | | | | | | | | | | | | | | $ in thousands | Principal/Notional Balance | | Unamortized Premium (Discount) | | Amortized Cost | | Unrealized Gain/ (Loss), net | | Fair Value | | Net Weighted Average Coupon (1) | | Period- end Weighted Average Yield (2) | | Quarterly Weighted Average Yield (3) | Agency RMBS: | | | | | | | | | | | | | | | | 15 year fixed-rate | 3,460,625 |
| | 151,526 |
| | 3,612,151 |
| | (54,223 | ) | | 3,557,928 |
| | 3.11 | % | | 2.19 | % | | 1.99 | % | 30 year fixed-rate | 2,780,806 |
| | 185,521 |
| | 2,966,327 |
| | 15,390 |
| | 2,981,717 |
| | 4.37 | % | | 2.61 | % | | 2.57 | % | ARM | 301,900 |
| | 2,520 |
| | 304,420 |
| | 3,453 |
| | 307,873 |
| | 2.69 | % | | 2.59 | % | | 2.16 | % | Hybrid ARM | 2,423,152 |
| | 42,360 |
| | 2,465,512 |
| | 8,789 |
| | 2,474,301 |
| | 2.70 | % | | 2.52 | % | | 2.02 | % | Total Agency pass-through(4) | 8,966,483 |
| | 381,927 |
| | 9,348,410 |
| | (26,591 | ) | | 9,321,819 |
| | 3.37 | % | | 2.42 | % | | 2.20 | % | Agency-CMO(5) | 1,712,120 |
| | (1,368,916 | ) | | 343,204 |
| | 837 |
| | 344,041 |
| | 2.16 | % | | 3.08 | % | | 2.07 | % | Non-Agency RMBS(6)(7)(8) | 3,838,314 |
| | (1,934,269 | ) | | 1,904,045 |
| | 91,506 |
| | 1,995,551 |
| | 2.21 | % | | 5.22 | % | | 5.22 | % | GSE CRT(9)(10) | 707,899 |
| | 24,320 |
| | 732,219 |
| | 35,981 |
| | 768,200 |
| | 2.38 | % | | 1.51 | % | | 1.24 | % | CMBS(11)(12) | 3,050,747 |
| | (559,857 | ) | | 2,490,890 |
| | 60,830 |
| | 2,551,720 |
| | 3.80 | % | | 4.21 | % | | 4.17 | % | Total | 18,275,563 |
| | (3,456,795 | ) | | 14,818,768 |
| | 162,563 |
| | 14,981,331 |
| | 3.05 | % | | 3.05 | % | | 2.87 | % |
| | (1) | Net weighted average coupon as of December 31, 2016 is presented net of servicing and other fees. |
| | (2) | Period-end weighted average yield is based on amortized cost as of December 31, 2016 and incorporates future prepayment and loss assumptions. |
| | (3) | Quarterly weighted average portfolio yield for the period was calculated by dividing interest income, including amortization of premiums and discounts, by the average balance of the amortized cost of the investments. All yields are annualized. |
| | (4) | We have elected the fair value option for Agency RMBS purchased on or after September 1, 2016 which represent 4.3% of principal/notional balance, 4.3% of amortized cost and 4.2% of fair value. |
| | (5) | Agency collateralized mortgage obligation ("Agency CMO") includes interest-only securities ("Agency IO"), which represent 85.5% of principal (notional) balance, 26.8% of amortized cost and 21.7% of fair value. |
| | (6) | Non-Agency RMBS held by us is 45.5% variable rate, 47.2% fixed rate, and 7.3% floating rate based on fair value. |
| | (7) | Of the total discount in non-Agency RMBS, $252.5 million is non-accretable based on estimated future cash flows of the securities. |
| | (8) | Non-Agency RMBS includes interest-only securities, which represent 43.5% of principal/notional balance, 1.5% of amortized cost and 1.3% of fair value. |
| | (9) | We have elected the fair value option for GSE CRT purchased on or after August 24, 2015, which represent 19.2% of the balance based on fair value. As a result, GSE CRT accounted for under the fair value option are not bifurcated between the debt host contract and the embedded derivative. |
| | (10) | GSE CRT weighted average coupon and weighted average yield excludes coupon interest associated with embedded derivatives not accounted for under the fair value option that is recorded as realized and unrealized credit derivative income (loss), net. |
| | (11) | CMBS includes interest-only securities which represent 20.3% of principal/notional balance, 0.8% of amortized cost and 0.9% of fair value. |
| | (12) | We have elected the fair value option for CMBS purchased on or after September 1, 2016 which represent 0.4% of principal/notional balance, 0.6% of amortized cost and 0.5% of fair value. |
The following table summarizes our non-Agency RMBS portfolio by asset type based on fair value as of June 30, 2017 and December 31, 2016. | | | | | | | | | | | | | $ in thousands | June 30, 2017 | | % of Non-Agency | | December 31, 2016 | | % of Non-Agency | Prime | 699,638 |
| | 44.4 | % | | 889,658 |
| | 44.6 | % | Alt-A | 421,492 |
| | 26.7 | % | | 447,213 |
| | 22.4 | % | Re-REMIC | 237,766 |
| | 15.1 | % | | 364,301 |
| | 18.2 | % | Subprime/reperforming | 216,944 |
| | 13.8 | % | | 294,379 |
| | 14.8 | % | Total Non-Agency | 1,575,840 |
| | 100.0 | % | | 1,995,551 |
| | 100.0 | % |
The following table summarizes the credit enhancement provided to our re-securitization of real estate mortgage investment conduit ("Re-REMIC") holdings as of June 30, 2017 and December 31, 2016. | | | | | | | | Percentage of Re-REMIC Holdings at Fair Value | Re-REMIC Subordination(1) | June 30, 2017 | | December 31, 2016 | 0% - 10% | 26.3 | % | | 17.6 | % | 10% - 20% | 3.9 | % | | 7.4 | % | 20% - 30% | 9.9 | % | | 13.5 | % | 30% - 40% | 19.4 | % | | 15.7 | % | 40% - 50% | 18.4 | % | | 27.0 | % | 50% - 60% | 20.3 | % | | 16.1 | % | 60% - 70% | 1.8 | % | | 2.7 | % | Total | 100.0 | % | | 100.0 | % |
| | (1) | Subordination refers to the credit enhancement provided to the Re-REMIC tranche held by us by any junior Re-REMIC tranche or tranches in a resecuritization. This figure reflects the percentage of the balance of the underlying securities represented by any junior tranche or tranches at the time of resecuritization. Generally, principal losses on the underlying securities in excess of the subordination amount would result in principal losses on the Re-REMIC tranche held by us. 48.3% of our Re-REMIC holdings are not senior tranches. |
The components of the carrying value of our MBS and GSE CRT portfolio at June 30, 2017 and December 31, 2016 are presented below. | | | | | | | $ in thousands | June 30, 2017 | | December 31, 2016 | Principal balance | 18,928,963 |
| | 18,275,563 |
| Unamortized premium | 484,242 |
| | 476,314 |
| Unamortized discount | (3,595,201 | ) | | (3,933,109 | ) | Gross unrealized gains | 379,923 |
| | 302,099 |
| Gross unrealized losses | (114,643 | ) | | (139,536 | ) | Fair value | 16,083,284 |
| | 14,981,331 |
|
The following table summarizes our MBS and GSE CRT portfolio according to estimated weighted average life classifications as of June 30, 2017 and December 31, 2016. | | | | | | | $ in thousands | June 30, 2017 | | December 31, 2016 | Less than one year | 117,913 |
| | 121,076 |
| Greater than one year and less than five years | 8,306,399 |
| | 6,719,923 |
| Greater than or equal to five years | 7,658,972 |
| | 8,140,332 |
| Total | 16,083,284 |
| | 14,981,331 |
|
The following tables present the estimated fair value and gross unrealized losses of our MBS and GSE CRTs by length of time that such securities have been in a continuous unrealized loss position at June 30, 2017 and December 31, 2016. June 30, 2017 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Less than 12 Months | | 12 Months or More | | Total | $ in thousands | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | Agency RMBS: | | | | | | | | | | | | | | | | | | 15 year fixed-rate | 2,534,116 |
| | (54,361 | ) | | 129 |
| | 111,912 |
| | (2,469 | ) | | 19 |
| | 2,646,028 |
| | (56,830 | ) | | 148 |
| 30 year fixed-rate | 1,351,307 |
| | (16,221 | ) | | 59 |
| | 507,832 |
| | (16,337 | ) | | 27 |
| | 1,859,139 |
| | (32,558 | ) | | 86 |
| ARM | 82,986 |
| | (89 | ) | | 9 |
| | — |
| | — |
| | — |
| | 82,986 |
| | (89 | ) | | 9 |
| Hybrid ARM | 799,528 |
| | (4,824 | ) | | 73 |
| | 7,048 |
| | (105 | ) | | 4 |
| | 806,576 |
| | (4,929 | ) | | 77 |
| Total Agency pass-through(1) | 4,767,937 |
| | (75,495 | ) | | 270 |
| | 626,792 |
| | (18,911 | ) | | 50 |
| | 5,394,729 |
| | (94,406 | ) | | 320 |
| Agency-CMO(2) | 124,257 |
| | (5,340 | ) | | 26 |
| | 21,443 |
| | (1,012 | ) | | 4 |
| | 145,700 |
| | (6,352 | ) | | 30 |
| Non-Agency RMBS | 113,298 |
| | (2,385 | ) | | 23 |
| | 166,184 |
| | (2,403 | ) | | 24 |
| | 279,482 |
| | (4,788 | ) | | 47 |
| CMBS(3) | 487,895 |
| | (8,767 | ) | | 42 |
| | 19,970 |
| | (330 | ) | | 5 |
| | 507,865 |
| | (9,097 | ) | | 47 |
| Total | 5,493,387 |
| | (91,987 | ) | | 361 |
| | 834,389 |
| | (22,656 | ) | | 83 |
| | 6,327,776 |
| | (114,643 | ) | | 444 |
|
| | (1) | Amounts disclosed include Agency RMBS with a fair value of $801.6 million for which the fair value option has been elected. Such securities have unrealized losses of $6.5 million. |
| | (2) | Fair value includes unrealized losses on Agency IO of $3.9 million and unrealized losses on CMO of $2.4 million. |
| | (3) | Amounts disclosed includes CMBS with a fair value of $168.0 million for which the fair value option has been elected. Such securities have unrealized losses of $2.3 million. |
December 31, 2016 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Less than 12 Months | | 12 Months or More | | Total | $ in thousands | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | | Fair Value | | Unrealized Losses | | Number of Securities | Agency RMBS: | | | | | | | | | | | | | | | | | | 15 year fixed-rate | 2,781,777 |
| | (66,506 | ) | | 127 |
| | 65,964 |
| | (1,556 | ) | | 17 |
| | 2,847,741 |
| | (68,062 | ) | | 144 |
| 30 year fixed-rate | 747,719 |
| | (15,409 | ) | | 45 |
| | 547,763 |
| | (18,004 | ) | | 27 |
| | 1,295,482 |
| | (33,413 | ) | | 72 |
| ARM | 120,540 |
| | (326 | ) | | 9 |
| | 1,091 |
| | (7 | ) | | 1 |
| | 121,631 |
| | (333 | ) | | 10 |
| Hybrid ARM | 1,356,687 |
| | (9,922 | ) | | 99 |
| | 252 |
| | (4 | ) | | 2 |
| | 1,356,939 |
| | (9,926 | ) | | 101 |
| Total Agency pass-through(1) | 5,006,723 |
| | (92,163 | ) | | 280 |
| | 615,070 |
| | (19,571 | ) | | 47 |
| | 5,621,793 |
| | (111,734 | ) | | 327 |
| Agency-CMO(2) | 163,114 |
| | (3,812 | ) | | 28 |
| | 22,792 |
| | (952 | ) | | 3 |
| | 185,906 |
| | (4,764 | ) | | 31 |
| Non-Agency RMBS | 287,647 |
| | (7,861 | ) | | 42 |
| | 497,863 |
| | (6,671 | ) | | 36 |
| | 785,510 |
| | (14,532 | ) | | 78 |
| GSE CRT(3) | — |
| | — |
| | — |
| | 35,935 |
| | (969 | ) | | 3 |
| | 35,935 |
| | (969 | ) | | 3 |
| CMBS(4) | 401,016 |
| | (6,733 | ) | | 36 |
| | 47,219 |
| | (804 | ) | | 6 |
| | 448,235 |
| | (7,537 | ) | | 42 |
| Total | 5,858,500 |
| | (110,569 | ) | | 386 |
| | 1,218,879 |
| | (28,967 | ) | | 95 |
| | 7,077,379 |
| | (139,536 | ) | | 481 |
|
| | (1) | Amounts disclosed include Agency RMBS with a fair value of $149.7 million for which the fair value option has been elected. Such securities have unrealized losses of $4.0 million. |
| | (2) | Fair value includes unrealized losses on Agency IO of $3.0 million unrealized losses and unrealized losses on CMO of $1.7 million. |
| | (3) | Fair value includes unrealized losses on both the debt host contract and the embedded derivative. |
| | (4) | Amounts disclosed includes CMBS with a fair value of $13.9 million for which the fair value option has been elected. Such securities have unrealized losses of $613,000. |
Gross unrealized losses on our Agency RMBS and CMO were $94.4 million and $2.4 million, respectively, at June 30, 2017. Due to the inherent credit quality of Agency RMBS and CMO, we determined that at June 30, 2017, any unrealized losses on our Agency RMBS and CMO portfolio are not other than temporary. Gross unrealized losses on our Agency IO, non-Agency RMBS, GSE CRT and CMBS were $17.8 million at June 30, 2017. We did not consider these unrealized losses to be credit related, but rather due to non-credit related factors such as interest rate spreads, prepayment speeds, and market fluctuations. These investment securities are included in our assessment for other-than-temporary impairment on a quarterly basis. We assess our investment securities for other-than-temporary impairment on a quarterly basis. When the fair value of an investment is less than its amortized cost at the balance sheet date of the reporting period for which impairment is assessed, the impairment is designated as either "temporary" or "other-than-temporary." This analysis includes a determination of estimated future cash flows through an evaluation of the characteristics of the underlying loans and the structural features of the investment. Underlying loan characteristics reviewed include, but are not limited to, delinquency status, loan-to-value ratios, borrower credit scores, occupancy status and geographic concentration. The following table represents the other-than-temporary impairment losses ("OTTI") included in earnings for the three and six months ended June 30, 2017 and 2016: | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | $ in thousands | 2017 | | 2016 | | 2017 | | 2016 | RMBS interest-only securities | 3,585 |
| | 1,472 |
| | 3,876 |
| | 7,155 |
| Non-Agency RMBS (1) | 513 |
| | 53 |
| | 754 |
| | 53 |
| Total | 4,098 |
| | 1,525 |
| | 4,630 |
| | 7,208 |
|
| | (1) | Amounts disclosed relate to credit losses on debt securities for which a portion of an other-than-temporary impairment was recognized in other comprehensive income. |
As we have previously elected the fair value option for RMBS interest-only securities, the OTTI was recorded as a reclassification from an unrealized to a realized loss within gain (loss) on investments, net on the condensed consolidated statements of operations. As of June 30, 2017, we did not intend to sell the securities and determined that it was not more likely than not that we will be required to sell the securities. The following table summarizes the changes in accumulated other comprehensive income (loss) related to our GSE CRT debt host contracts and available-for-sale MBS for the three and six months ended June 30, 2017 and 2016. We reclassify unrealized gains and losses from other comprehensive income to gain (loss) on investments, net when we sell our investments. The table excludes MBS and GSE CRT that are accounted for under the fair value option. As of June 30, 2017, $3.1 billion or 19.3% of our MBS and GSE CRT are accounted for under the fair value option. | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | $ in thousands | 2017 | | 2016 | | 2017 | | 2016 | Accumulated other comprehensive income (loss) from MBS and GSE CRT securities: | | | | | | | | Unrealized gain (loss) on MBS and GSE CRT at beginning of period | 163,440 |
| | 288,715 |
| | 146,301 |
| | 177,799 |
| Unrealized gain (loss) on MBS and GSE CRT | 39,633 |
| | 117,116 |
| | 55,922 |
| | 238,576 |
| Reclassification of unrealized (gain) loss on sale of MBS and GSE CRT to gain (loss) on investments, net | 651 |
| | (1,037 | ) | | 1,501 |
| | (11,581 | ) | Balance at the end of period | 203,724 |
| | 404,794 |
| | 203,724 |
| | 404,794 |
|
The following table summarizes the components of our total gain (loss) on investments, net for the three and six months ended June 30, 2017 and 2016. | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | $ in thousands | 2017 | | 2016 | | 2017 | | 2016 | Gross realized gains on sale of investments | 1,311 |
| | 1,037 |
| | 2,215 |
| | 14,052 |
| Gross realized losses on sale of investments | (1,962 | ) | | — |
| | (3,873 | ) | | (2,471 | ) | Other-than-temporary impairment losses | (4,098 | ) | | (1,525 | ) | | (4,630 | ) | | (7,208 | ) | Net unrealized gains and losses on MBS accounted for under the fair value option | 7,715 |
| | 1,266 |
| | 4,113 |
| | 7,942 |
| Net unrealized gains and losses on GSE CRT accounted for under the fair value option | 8,195 |
| | 173 |
| | 11,474 |
| | 237 |
| Net unrealized gains and losses on trading securities | 14 |
| | 463 |
| | 23 |
| | 463 |
| Total gain (loss) on investments, net | 11,175 |
| | 1,414 |
| | 9,322 |
| | 13,015 |
|
The following table presents components of interest income recognized on our MBS and GSE CRT portfolio for the three and six months ended June 30, 2017 and 2016. GSE CRT interest income excludes coupon interest associated with embedded derivatives not accounted for under the fair value option that is recorded as realized and unrealized credit derivative income (loss), net. For the three months ended June 30, 2017 | | | | | | | | | | $ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income | Agency | 91,979 |
| | (27,775 | ) | | 64,204 |
| Non-Agency | 18,131 |
| | 3,734 |
| | 21,865 |
| GSE CRT | 5,556 |
| | (347 | ) | | 5,209 |
| CMBS | 31,506 |
| | (1,852 | ) | | 29,654 |
| Other | 95 |
| | — |
| | 95 |
| Total | 147,267 |
| | (26,240 | ) | | 121,027 |
|
For the three months ended June 30, 2016 | | | | | | | | | | $ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income | Agency | 84,440 |
| | (28,277 | ) | | 56,163 |
| Non-Agency | 24,127 |
| | 2,292 |
| | 26,419 |
| GSE CRT | 2,136 |
| | (775 | ) | | 1,361 |
| CMBS | 31,476 |
| | (2,839 | ) | | 28,637 |
| Other | 297 |
| | (17 | ) | | 280 |
| Total | 142,476 |
| | (29,616 | ) | | 112,860 |
|
For the six months ended June 30, 2017 | | | | | | | | | | $ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income | Agency | 183,210 |
| | (56,353 | ) | | 126,857 |
| Non-Agency | 38,745 |
| | 8,121 |
| | 46,866 |
| GSE CRT | 10,043 |
| | (718 | ) | | 9,325 |
| CMBS | 61,182 |
| | (4,486 | ) | | 56,696 |
| Other | 156 |
| | — |
| | 156 |
| Total | 293,336 |
| | (53,436 | ) | | 239,900 |
|
For the six months ended June 30, 2016 | | | | | | | | | | $ in thousands | Coupon Interest | | Net (Premium Amortization)/Discount Accretion | | Interest Income | Agency | 170,211 |
| | (52,462 | ) | | 117,749 |
| Non-Agency | 49,976 |
| | 6,136 |
| | 56,112 |
| GSE CRT | 4,333 |
| | (1,542 | ) | | 2,791 |
| CMBS | 63,740 |
| | (5,779 | ) | | 57,961 |
| Other | 510 |
| | (17 | ) | | 493 |
| Total | 288,770 |
| | (53,664 | ) | | 235,106 |
|
|